-The Times of India MUMBAI: Unable to prevent prices of vegetables and fruits from going through the roof, the state government is now promising their supply to Mumbaikars at reduced rates, a promise observers say needs to be taken with a pile of salt. Starting Monday, the government will-for the first time since 1999-sell vegetables and fruits at a price 30% lower than the current retail rate at select co-operative outlets...
More »SEARCH RESULT
Ranbaxy drugs safe says Australian drug regulator
-The Economic Times NEW DELHI: After the UK drug regulator, the Australian drug regulator has also said that the drugs marketed by Ranbaxy Labs are safe. "At present, there is no evidence that any of the products in the Australian market manufactured by Ranbaxy are of an unacceptable quality or that there is a danger to consumers in Australia," a spokesperson for the Australian Therapeutic Goods Administration (TGA) told ET. The Australian...
More »When incomes grow, but jobs elude -Sonalde Desai
-The Indian Express The latest NSSO data also underlines the increasing absence of women from the labour market Every time results from one of the "thick" rounds of the National Sample Survey come out, we get into a feeding frenzy, trying to slice and dice the statistics for changes since the previous round. Since NSS large rounds are typically conducted every five years, there is perhaps some sense to it, particularly when...
More »CCEA okays sale of 10.5 mn tonne FCI foodgrains in open market
-PTI NEW DELHI: The Cabinet Committee on Economic Affairs (CCEA) today cleared the Food Ministry's proposal to offload 10.5 million tonnes of FCI foodgrains in the open market to control retail prices. However, the proposal on allowing extra 2 million tonnes of wheat export through public sector trading agencies was not listed on the CCEA agenda for discussion. "The CCEA has approved allocation of 10 million tonnes of wheat and 0.5 million tonnes...
More »USFDA scrutiny: Will pharma majors like Ranbaxy, Wockhardt be affected in long-term? -G Seetharaman
-The Economic Times Japanese companies do not mind erring on the side of caution. They are known to think longer and harder than their counterparts in other countries about big decisions, especially when it comes to entering a new market or acquiring a foreign company. But Japan's third biggest drugmaker Daiichi Sankyo would now wish it had spent more time doing due diligence on Ranbaxy Labs, in which it bought a...
More »